Biopeptek Pharmaceuticals LLC

Your reliable peptides partner.

610-643-4881
Request A Quote
Menu
  • Home
  • Products & Services
      • Peptide APIs
      • Research Peptides
      • Catalog Peptides
      • cGMP Peptide Manufacturing
      • Full Service CDMO
    • Close
  • Peptide Resources
    • Peptide Handling
      • Dissolving Charged Peptides
      • Dissolving Peptides
      • Dissolving Uncharged Peptides
      • Lyophilized Peptides Storage
      • Peptide Solubility
      • Peptide Stability and Degradation
    • Peptide Modifications
      • Antibody Modifications
      • Disulfide Bridges/Bonds
      • Fluorescent Modifications
      • Peptide Cyclization
      • Standard Modifications
    • Fluorophore Properties
    • Design Peptide Antigen
    • RNA Codon Table
    • FAQs
    • Close
  • About Biopeptek
    • Who we are
    • Management Team
    • Events
    • Careers
    • Close
  • Contact Us
    • Close
Home / Peptide Resources / Peptide Modifications / Antibody Modifications
Request A Quote

Peptide Resources

  • Peptide Modifications
    • Antibody Modifications
    • Fluorescent Modifications
    • FRET Peptides
    • Peptide Cyclization
    • Standard Modifications
  • Peptide Handling
    • Dissolving Charged Peptides
    • Dissolving Peptides
    • Dissolving Uncharged Peptides
    • Lyophilized Peptides Storage
    • Peptide Solubility
    • Peptide Stability and Degradation
  • Fluorophore Properties
  • Design Peptide Antigen
  • RNA Codon Table

Antibody Modifications

KLH, BSA, OVA Conjugates

Peptide-protein conjugates are used for custom antibody production against peptides. Peptides alone are mostly too small to elicit a sufficient immune response, so carrier proteins containing many epitopes help to stimulate T-helper cells, which help induce the B-cell response.
It is important to remember that the immune system reacts to the peptide-protein conjugate as a whole so there will always be a portion of antibodies to the peptide synthesis, the linker and the carrier protein.

Among the most common carrier proteins one can find:

  • KLH (Keyhole Limpet Hemocyanin), a copper containing, non-heme protein found in arthropods and mollusca. It is isolated from Megathura crenulata and has a MW of 4.5 x 105 ~ 1.3 x 107 Da. KLH is the most commonly selected carrier due to its higher immunogenicity compared to BSA.
  • BSA (Bovine Serum Albumin), a plasma protein in cattle, belonging to the most stable and soluble albumins. It has a MW of 67 x 103 Da containing 59 lysines. About 30-35 of these primary amines are accessible for linker conjugation, which makes BSA a popular carrier protein for weak antigenic compounds. A disadvantage of BSA is that it is used in many experiments as a blocking buffer reagent. If antisera against peptide-BSA conjugates are used in such assays, false positives can occur, because these sera also contain antibodies to BSA.
  • OVA (Ovalbumin), a protein isolated from hen egg whites, with a MW of 45 x 103 Da. It is a good choice as second carrier protein to verify if antibodies are specific for the peptide alone and not the carrier protein (e.g. BSA).

MAPs (Multiple peptide antigen)

MAPs are branched peptides that can be used for direct immunization to produce antibodies. MAPs are usually big enough to raise the immune response.
The antigenic peptide of interest is being synthesized directly on the branched MAP structure. MAPs are available as MAP 4 (4 branches) or MAP 8 (8 branches) molecules:

Schematic graph of a MAP 8 and a peptide-protein conjugate:

MAP 8
peptide-protein conjugate
Home / Peptide Resources / Peptide Modifications / Antibody Modifications
Request A Quote

Biopeptek Pharmaceuticals LLC

  • 5 Great Valley Parkway, Suite 100 Malvern, PA 19355
  • (610) 643-4881
  • info@biopeptek.com

Quick Links

  • Products & Services
  • Peptide Resources
  • About
  • Press Releases
  • Events
  • Contact

Stay Connected


Sign up to receive news and updates.

Copyright © 2023 · Biopeptek Pharmaceuticals LLC. All rights reserved

Biopeptek Pharmaceuticals LLC
  • Home
  • Products & Services
    ▼
    • [Column]
      ▼
      • Peptide APIs
      • Research Peptides
      • Catalog Peptides
    • [Column]
      ▼
      • cGMP Peptide Manufacturing
      • Full Service CDMO
  • Peptide Resources
    ▼
    • Peptide Handling
      ▼
      • Dissolving Charged Peptides
      • Dissolving Peptides
      • Dissolving Uncharged Peptides
      • Lyophilized Peptides Storage
      • Peptide Solubility
      • Peptide Stability and Degradation
    • Peptide Modifications
      ▼
      • Antibody Modifications
      • Disulfide Bridges/Bonds
      • Fluorescent Modifications
      • Peptide Cyclization
      • Standard Modifications
    • Fluorophore Properties
    • Design Peptide Antigen
    • RNA Codon Table
    • FAQs
  • About Biopeptek
    ▼
    • Who we are
    • Management Team
    • Events
    • Careers
  • Contact Us
  • Search
    ▼
    • [Custom]